Date | Title | Description | _References |
01.02.2022 | Fractyl Health Publishes Two-Year Durability Data After a Si... | ;LEXINGTON, MA., February 1, 2022 - Fractyl Health, an organ-editing metabolic therapeutics company ... | - |
21.04.2021 | Antios Therapeutics Doses First Patients in SAVE 1, a Phase ... | ;MENDHAM, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. (“Antios”) today announ... | - |
24.02.2020 | Antios Therapeutics Announces Notice of Allowance for a U.S.... | ;ATLANTA, Feb. 24, 2020 /PRNewswire/ -- Antios Therapeutics, Inc. ("Antios"), a clinical-s... | - |
09.01.2020 | Omniome Closes $60 Million Series C Financing To Advance Nov... | ;SAN DIEGO—January 9, 2020 – Omniome, Inc., developer of an innovative DNA sequencing platform capab... | - |
12.12.2019 | Aspen Neuroscience Launches With $6.5 Million Seed Funding t... | ;SAN DIEGO, Dec. 12, 2019 — Aspen Neuroscience, Inc. today announced its launch following a $6.5 mil... | - |
09.12.2019 | Achillion Reports Positive Data from Phase 2 Study of Danico... | ;BLUE BELL, Pa., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a... | - |
11.11.2019 | Achillion Announces Clearance of Investigational New Drug Ap... | ;BLUE BELL, Pa., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a... | - |
25.10.2019 | Bempedoic Acid Included in Top 10 Medical Innovations for 20... | ;ANN ARBOR, Mich., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) announced that bempedoic... | - |
22.10.2019 | Obalon Announces First Patient Treatments at its First Compa... | ;SAN DIEGO, CA, October 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weig... | - |
21.10.2019 | Veracyte Announces New Data Demonstrating That Envisia Genom... | ;SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 21, 2019-- Veracyte, Inc. (Nasdaq: VCYT) announc... | - |
17.10.2019 | Marinus Phase 2 Clinical Data on Ganaxolone in RSE Presented... | ;RADNOR, Pa., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marin... | - |
16.10.2019 | Alexion to Acquire Achillion | ;BOSTON & BLUE BELL, Pa.--(BUSINESS WIRE)--Oct. 16, 2019-- Alexion Pharmaceuticals, Inc. (NASDAQ... | - |
11.10.2019 | FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in... | ;Eli Lilly won FDA approval for a migraine drug on Friday, giving the pharmaceutical giant a second ... | - |
07.10.2019 | Veracyte to Announce New Clinical Data for First Noninvasive... | ;SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 7, 2019-- Veracyte, Inc. (Nasdaq: VCYT) today an... | - |
03.10.2019 | Milestone Pharmaceuticals Announces First Patient Enrolled i... | ;MONTREAL and CHARLOTTE, N.C., Oct. 3, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: ... | - |
10.09.2019 | Milestone Pharmaceuticals Announces Appointment of Amit Hasi... | ;MONTREAL and CHARLOTTE, N.C., Sept. 10, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq... | - |
13.08.2019 | Milestone Pharmaceuticals Provides Positive Regulatory Updat... | ;MONTREAL and CHARLOTTE, N.C., Aug. 13, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq:... | - |
25.06.2019 | WindMIL Therapeutics Announces FDA Clearance of Investigatio... | ;BALTIMORE, MD AND PHILADELPHIA, PA – June 25, 2019 – WindMIL Therapeutics, a clinical-stage company... | - |
14.05.2019 | Milestone Pharmaceuticals Announces Full Exercise of Underwr... | ;MONTREAL and CHARLOTTE, N.C., May 14, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: ... | - |
08.05.2019 | Milestone Pharmaceuticals Announces Pricing of Upsized Initi... | ;MONTREAL and CHARLOTTE, N.C., May 8, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: M... | - |
06.05.2019 | Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre... | ;SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage bioph... | - |
16.04.2019 | Milestone Pharmaceuticals Appoints Paul Edick Chairman of it... | ;Montreal, QC, CA, and Charlotte, NC, April 16, 2019 – Milestone Pharmaceuticals, a late-stage bioph... | - |
04.04.2019 | Milestone Pharmaceuticals Appoints Michael Tomsicek to Board... | ;Montreal, QC, CA, and Charlotte, NC, April 4, 2019 – Milestone Pharmaceuticals, a late-stage biopha... | - |
19.03.2019 | Iterum Therapeutics Receives QIDP for Oral and IV Sulopenem ... | ;DUBLIN, Ireland and CHICAGO, March 19, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: IT... | - |
18.09.2018 | Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials o... | ;DUBLIN, Ireland and CHICAGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: IT... | - |
17.09.2018 | U.S. FDA Clears Sebacia Microparticles for the Treatment of ... | ;Duluth, GA – September 17, 2018 – Sebacia, Inc., a privately held, commercial stage dermatology and... | - |
09.08.2018 | Iterum Initiates SURE 1, a Phase 3 Clinical Trial of Oral Su... | ;DUBLIN and CHICAGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a cli... | - |
02.08.2018 | Celtaxsys Announces Results of Phase 2 Trial Showing Clinica... | ;ATLANTA – August 2, 2018 – Celtaxsys, Inc., a clinical stage pharmaceutical development company foc... | - |
04.01.2018 | Celtaxsys Secures Private Financing to Advance Acebilustat P... | ;Atlanta, GA – (January 4, 2018) – Celtaxsys, Inc., a clinical stage drug development company focuse... | - |
24.10.2017 | Milestone Pharmaceuticals Appoints Lorenz Muller as Chief Co... | ;;CHARLOTTE, N.C., Oct. 24, 2017 /PRNewswire/ -- Milestone Pharmaceuticals USA, Inc., a clinical sta... | - |
02.10.2017 | Esperion Completes Patient Enrollment in Global Pivotal Phas... | ;ANN ARBOR, Mich., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the ... | - |
26.09.2017 | FierceBiotech's 2017 Fierce 15 | ;The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the best... | - |
21.08.2017 | IntegenX Applauds the Passage of the Rapid DNA Act of 2017 | ;;PLEASANTON, Calif.--(BUSINESS WIRE)--IntegenX Inc., the global market leader for Rapid DNA human i... | - |
01.08.2017 | Milestone Pharmaceuticals Closes $55 Million Series C Financ... | ;;MONTREAL, August 1, 2017 /PRNewswire/ -- Milestone Pharmaceuticals Montreal, Canada, Inc., a clini... | - |
25.07.2017 | Sebacia grabs $36M to push gold microparticle acne treatment... | ;;Sebacia, which already markets its gold-and-silica microparticle acne treatment in Europe, raised ... | - |
25.07.2017 | Iterum Gains Important Support for Development of Novel Oral... | ;;DUBLIN, IRELAND – July 25th, 2017 – Iterum Therapeutics Limited, a clinical-stage pharmaceutical c... | - |
29.06.2017 | FDA Grants Orphan Drug Designation for Ganaxolone in CDKL5 D... | ;RADNOR, Pa., June 29, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a bioph... | - |
27.06.2017 | Marinus Pharmaceuticals Launches the Ganaxolone Clinical Pro... | ;;RADNOR, Pa., June 27, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biop... | - |
26.06.2017 | Esperion Announces FDA Confirmation of Regulatory Pathway to... | ;;Ann Arbor, Mich., -- (Globe Newswire – June 26, 2017) -- Esperion Therapeutics, Inc. (NASDAQ: ESPR... | - |
19.05.2017 | Iterum Secures $65 Million in Series B Financing | ;DUBLIN, IRELAND, and CHICAGO – May 19, 2017 – Iterum Therapeutics Limited, an Irish clinical-stage ... | - |
17.05.2017 | Syndax Announces Results from Phase 2 ENCORE 601 Trial of En... | ;;WALTHAM, Mass., May 17, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. ("Syndax,"... | - |
11.05.2017 | Milestone Pharmaceuticals Announces Etripamil Phase 2 Clinic... | ;;MONTREAL, May 11, 2017 /PRNewswire/ -- Milestone Pharmaceuticals Montreal, Canada, Inc., a clinica... | - |
11.05.2017 | FIRST EVER NASAL SPRAY THERAPY SUCCESSFUL IN TREATING RAPID ... | ;;CHICAGO, May 11, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness o... | - |
27.04.2017 | ChromaCode Raises $12 Million in Series B for Commercial Lau... | ;;CARLSBAD, Calif., April 27, 2017 /PRNewswire/ -- ChromaCode, Inc., a molecular diagnostics company... | - |
18.04.2017 | MARINUS TO PRESENT GANAXOLONE DATA AT AMERICAN ACADEMY OF NE... | ;;RADNOR, PA, April 18, 2017 (Globe Newswire) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biop... | - |
12.04.2017 | Milestone Pharmaceuticals to Present Etripamil Phase 2 Data ... | ;;MONTREAL, April 12, 2017 /PRNewswire/ -- Milestone Pharmaceuticals Montreal, Canada, Inc., a clini... | - |
21.03.2017 | USPTO Grants Composition of Matter Patent to Achillion for S... | ;NEW HAVEN, Conn., March 21, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) ... | - |
20.03.2017 | Esperion Announces FDA Confirmation Regarding Regulatory Pat... | ;;Ann Arbor, Mich., -- (Globe Newswire – March 20, 2017) – Esperion Therapeutics, Inc. (NASDAQ:ESPR)... | - |
06.03.2017 | Esperion Announces Oral Presentation on Genetic Validation o... | ;;ANN ARBOR, Mich., March 06, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), th... | - |
01.02.2017 | Marinus Appoints Michael R. Dougherty to its Board of Direct... | ;;RADNOR, PA, February 1, 2017 (Globe Newswire) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a bi... | - |
25.01.2017 | Esperion Completes Enrollment of Pivotal Phase 3 Long-Term S... | ;;ANN ARBOR, Mich., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the... | - |
23.01.2017 | MARINUS ANNOUNCES POSITIVE PRELIMINARY DATA FROM CHILDREN WI... | ;;RADNOR, PA, January 23, 2017 (Globe Newswire) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), toda... | - |
08.01.2017 | Esperion Announces Initiation of Three Pivotal Phase 3 Studi... | ;;Ann Arbor, Mich., -- (Globe Newswire – January 8, 2017) -- Esperion Therapeutics, Inc. (NASDAQ: ES... | - |
05.01.2017 | Marinus Provides Business Outlook for 2017 | ;;RADNOR, PA, January 5, 2017 (Globe Newswire) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a bio... | - |
23.12.2016 | TWO PEER-REVIEWED PUBLICATIONS HIGHLIGHT CLINICAL UTILITY OF... | ;;SALT LAKE CITY, December 19, 2016 – Sera Prognostics, Inc., a women’s healthcare company, today an... | - |
01.12.2016 | Axial Biotherapeutics Announces the Groundbreaking Discovery... | ;;BOSTON, December 1, 2016 – Axial Biotherapeutics today announced that researchers from the Califor... | - |
30.11.2016 | Axial Biotherapeutics Launches to Treat Patients with CNS Di... | ;;BOSTON, November 30, 2016 – Axial Biotherapeutics today announced the launch of the Company with a... | - |
28.11.2016 | Esperion Therapeutics Announces Publication of Definitive Pa... | ;ANN ARBOR, Mich., Nov. 28, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a ph... | - |
20.09.2016 | Allergan to Acquire Tobira Therapeutics Expanding Global GI ... | ;;DUBLIN and SAN FRANCISCO, Sept. 20, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading globa... | - |
06.09.2016 | ROX Medical Raises $40M Financing | ;;SAN CLEMENTE, Calif., Sept. 6, 2016 /PRNewswire/ -- ROX Medical, a privately held clinical-stage m... | - |
07.07.2016 | GENOMIC HEALTH AND EPIC SCIENCES ANNOUNCE STRATEGIC COLLABOR... | ;;REDWOOD CITY AND SAN DIEGO, CA, July 6, 2016;Genomic Health, Inc. (Nasdaq: GHDX) and Epic Sciences... | - |
22.06.2016 | Marinus Pharmaceuticals Doses First Subject in Phase 1 Clini... | ;;RADNOR, Pa., June 22, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biop... | - |
06.06.2016 | Celator Pharmaceuticals(R) Presented Phase 3 Trial Results i... | ;;EWING, N.J., June 6, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today annou... | - |
31.05.2016 | JAZZ PHARMACEUTICALS AND CELATOR PHARMACEUTICALS ANNOUNCE AG... | ;;DUBLIN and EWING, N.J., May 31, 2016 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Celator Pharma... | - |
19.05.2016 | Celator Pharmaceuticals® Announces VYXEOS™ Granted Breakthro... | ;;EWING, N.J., May 19, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today annou... | - |
09.05.2016 | Aldeyra Therapeutics Announces Positive Results From Phase I... | ;;LEXINGTON, MA -- (Marketwired) -- 05/09/16 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra),... | - |
03.05.2016 | Achillion Reports First Quarter 2016 Financial Results and P... | ;;NEW HAVEN, Conn., May 03, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) t... | - |
21.04.2016 | Celator® Pharmaceuticals to Present Phase 3 Data at 2016 Ame... | ;;EWING, N.J., April 21, 2016/PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX) today annou... | - |
15.04.2016 | Marinus Pharmaceuticals Receives FDA Orphan Drug Designation... | ;;RADNOR, Pa., April 15, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a bio... | - |
11.04.2016 | Syndax Announces Entinostat Data to be Presented at the Amer... | ;;WALTHAM, Mass., April 11, 2016 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a c... | - |
31.03.2016 | Celator(R) Pharmaceuticals Announces New Data for VYXEOS(TM)... | ;;EWING, N.J., March 31, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today ann... | - |
31.03.2016 | REVA MEDICAL, INC. (ASX: RVA) ("REVA" OR THE "... | ;;SAN DIEGO, CALIFORNIA AND SYDNEY, AUSTRALIA (WEDNESDAY, 30 MARCH 2016, AEDT) - REVA MEDICAL, INC. ... | - |
21.03.2016 | Celator(R) Pharmaceuticals Announces Business Update and Fou... | ;;EWING, N.J., March 21, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX), a biopha... | - |
16.03.2016 | New Data Show That Veracyte’s Afirma® Gene Expression Classi... | ;;SOUTH SAN FRANCISCO, Calif., March 16, 2016 --- Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnos... | - |
14.03.2016 | Celator Announces Phase 3 Trial for VYXEOS™ (CPX-351) in Pat... | ;;EWING, N.J., March 14, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today ann... | - |
10.03.2016 | Landmark Study Published in American Journal of Obstetrics &... | ;;SALT LAKE CITY, March 10, 2016 – Sera Prognostics, Inc., a women’s healthcare company, today annou... | - |
29.02.2016 | Aldeyra Therapeutics Reports Positive Results from Phase IIa... | ;;LEXINGTON, Mass., February 29, 2016 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (... | - |
23.02.2016 | CoLucid Pharmaceuticals Announces Confirmatory Support for N... | ;;CAMBRIDGE, Mass., Feb. 23, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), a... | - |
11.02.2016 | Achillion Initiates Phase 1 Study of ACH-4471, First Orally-... | ;;NEW HAVEN, Conn., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) ... | - |
21.01.2016 | INTERNATIONAL STUDY SHOWS 3-YEAR BENEFITS OF GLAUKOS ISTENT®... | ;;LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical te... | - |
21.01.2016 | Five Prime Therapeutics Announces Preliminary Data From the ... | ;;SOUTH SAN FRANCISCO, Calif., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasd... | - |
20.01.2016 | Allan L. Shaw Joins Syndax Pharmaceuticals As Chief Financia... | ;;WALTHAM, Mass., Jan. 20, 2016 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical stage bioph... | - |
13.01.2016 | Esperion Therapeutics Announces Initiation of Phase 3 Clinic... | ;;ANN ARBOR, Mich., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a p... | - |
12.01.2016 | Esperion Therapeutics Announces Initiation of Phase 2 Clinic... | ;;ANN ARBOR, Mich., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a p... | - |
11.01.2016 | Achaogen Announces Enrollment of First Patient in EPIC, a Ph... | ;;SOUTH SAN FRANCISCO, CA, USA I January 11, 2016 I Achaogen, Inc. (AKAO), a clinical-stage biopharm... | - |
11.01.2016 | Five Prime Therapeutics Provides Update on FP-1039 Clinical ... | ;;SOUTH SAN FRANCISCO, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasd... | - |
11.01.2016 | Celator(R) Pharmaceuticals Announces Participation in Cardif... | ;;EWING, N.J., Jan. 11, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX) today annou... | - |
07.01.2016 | Tobira Therapeutics Announces Initiation of Program to Evalu... | ;;SOUTH SAN FRANCISCO, Calif., Jan. 7, 2016 /PRNewswire/ -- Tobira Therapeutics, Inc. (NASDAQ: TBRA)... | - |
07.01.2016 | Veracyte Announces Expansion to New South San Francisco Faci... | ;;SOUTH SAN FRANCISCO, Calif., Jan. 7, 2016 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT), a molecul... | - |
05.01.2016 | BioNano Genomics Highlights Study Using Next-Generation Mapp... | ;;SAN DIEGO, Jan. 05, 2016 (GLOBE NEWSWIRE) -- BioNano Genomics, the leader in physical genome mappi... | - |
04.01.2016 | Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce C... | ;;Darmstadt, Germany, New York, US and Waltham, Mass., US, January 4, 2016 – Merck KGaA, Darmstadt, ... | - |
17.12.2015 | Navihealth Acquires Rightcare Solutions | ;Navihealth Acquires Rightcare Solutions
-Company is a Leader in Post-Acute Decision Support and Re... | - |
15.12.2015 | Alimera Sciences Signs Agreement To Distribute ILUVIEN® In T... | ;;ATLANTA, Dec. 15, 2015 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmace... | - |
14.12.2015 | Veracyte Announces Positive Coverage Policy for the Afirma® ... | ;;SOUTH SAN FRANCISCO, Calif., December 14, 2015 --- Veracyte, Inc. (NASDAQ: VCYT), a molecular diag... | - |
11.12.2015 | Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatm... | ;;SAN DIEGO, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical comp... | - |
08.12.2015 | Afferent Pharmaceuticals Advances Novel Molecule, AF-130, to... | ;;December 08, 2015 08:00 AM Eastern Standard Time
SAN MATEO, Calif.--(BUSINESS WIRE)--Afferent Pha... | - |
08.12.2015 | Tobira Therapeutics Announces Data Presentations Highlightin... | ;;SOUTH SAN FRANCISCO, Calif., Dec. 8, 2015 /PRNewswire/ -- Tobira Therapeutics, Inc. (NASDAQ: TBRA)... | - |
07.12.2015 | Neothetics Announces Issuance by USPTO of Fourth Patent Dire... | ;;SAN DIEGO, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage speci... | - |
06.12.2015 | Atara Bio Announces Positive Results From a Phase 2 Clinical... | ;;SOUTH SAN FRANCISCO, Calif., Dec. 06, 2015 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq... | - |
03.12.2015 | Syndax Announces Multiple Data Presentations On Entinostat A... | ;;WALTHAM, Mass., Dec. 3, 2015 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical stage biopha... | - |
01.12.2015 | Syndax Announces Initiation Of Entinostat Clinical Program I... | ;;WALTHAM, Mass., Dec. 1, 2015 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical stage biopha... | - |